LFG
AVXL icon

Larson Financial Group’s Anavex Life Sciences AVXL Stock Holding History

Larson Financial Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-614
Closed -$1.89K – 3784
2026
Q1 		$1.89K Sell
614
-625
-50% -$2.71K ﹤0.01% 2973
2025
Q4 		$4.41K Buy
1,239
+650
+110% +$3.98K ﹤0.01% 2507
2025
Q3 		$5.24K Buy
589
+39
+7% +$396 ﹤0.01% 2338
2025
Q2 		$5.07K Sell
550
-19
-3% -$162 ﹤0.01% 2064
2025
Q1 		$4.88K Sell
569
-8
-1% -$76 ﹤0.01% 1888
2024
Q4 		$6.2K Sell
577
-638
-53% -$4.91K ﹤0.01% 1615
2024
Q3 		$6.9K Hold
1,215
– – ﹤0.01% 1604
2024
Q2 		$5.13K Hold
1,215
– – ﹤0.01% 1440
2024
Q1 		$6.18K Buy
1,215
+205
+20% +$1.15K ﹤0.01% 1150
2023
Q4 		$9.4K Hold
1,010
– – ﹤0.01% 1033
2023
Q3 		$6.62K Hold
1,010
– – ﹤0.01% 1107
2023
Q2 		$8.21K Hold
1,010
– – ﹤0.01% 992
2023
Q1 		$8.66K Buy
1,010
+15
+2% +$150 ﹤0.01% 963
2022
Q4 		$9.21K Buy
995
+445
+81% +$4.75K ﹤0.01% 884
2022
Q3 		$6K Hold
550
– – ﹤0.01% 908
2022
Q2 		$6K Hold
550
– – ﹤0.01% 817
2022
Q1 		$7K Hold
550
– – ﹤0.01% 722
2021
Q4 		$10K Hold
550
– – ﹤0.01% 679
2021
Q3 		$10K Hold
550
– – ﹤0.01% 585
2021
Q2 		$13K Hold
550
– – ﹤0.01% 507
2021
Q1 		$8K Hold
550
– – ﹤0.01% 578
2020
Q4 		$3K Hold
550
– – ﹤0.01% 593
2020
Q3 		$3K Hold
550
– – ﹤0.01% 560
2020
Q2 		$3K Hold
550
– – ﹤0.01% 520
2020
Q1 		$2K Hold
550
– – ﹤0.01% 421
2019
Q4 		$1K Hold
550
– – ﹤0.01% 486
2019
Q3 		$2K Hold
550
– – ﹤0.01% 426
2019
Q2 		$2K Hold
550
– – ﹤0.01% 377
2019
Q1 		$2K Hold
550
– – ﹤0.01% 368
2018
Q4 		$1K Buy
+550
New +$1.25K ﹤0.01% 388

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Larson Financial Group's AVXL Position: Q2 2026 in Review

Larson Financial Group sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 614 shares — an estimated $1.89K sold.

Larson Financial Group first reported a position in AVXL in Q4 2018 and held it in 30 quarters. The position peaked at $13K in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Larson Financial Group reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Larson Financial Group sold 614 Anavex Life Sciences shares in Q2 2026, an estimated $1.89K.
  • Larson Financial Group first reported a position in Anavex Life Sciences in Q4 2018 and held it in 30 quarters.
  • Larson Financial Group's Anavex Life Sciences position peaked at $13K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.